ModuleDraftMedications

Study module: secondary stroke prevention deep dive (etiology → therapy mapping)

Clinician study module that organizes secondary prevention by stroke subtype (cardioembolic/large artery/small vessel/cryptogenic) and links each to workup + prevention strategy concepts (no prescribing).

ClinicianClinicianAdvanced30 minClinical (pro)

Educational only

Educational only — treatment decisions require clinician judgment and patient-specific context.

Get help now

New or worsening neurologic deficit is an emergency: activate local stroke alert/emergency response immediately and document last known well time. Prevention mapping should not delay acute care.

Key takeaways

  • Explain why etiology drives prevention strategy
  • List standard secondary prevention domains (BP, lipids, antithrombotics)
  • Differentiate antiplatelet vs anticoagulation indications conceptually
  • Identify common follow-up/monitoring needs

Etiology framework

  • Large artery atherosclerosis
  • Cardioembolic
  • Small vessel
  • Other/cryptogenic

Workup-to-therapy mapping (concept)

  • AFib → anticoagulation consideration
  • Carotid disease → revascularization consideration
  • Lacunar → risk factor control

Risk factor pillars

  • BP control
  • Lipid management
  • Diabetes management
  • Smoking cessation
  • Activity and diet

Systems of care

  • Medication adherence supports
  • Follow-up cadence
  • Care transitions

Practice check

What you’ll practice

These questions are untimed. After you answer all of them, you’ll see your score and a clear next lesson or reference step.

0 of 3 answered

Question 1

1. Secondary prevention strategy is most dependent on…

Question 2

2. AFib-related strokes often involve anticoagulation considerations.

Question 3

3. Key pillars of secondary prevention include…

References

  1. Tier 1
    AHA/ASA 2021 Guideline for Prevention of Stroke in Patients With Stroke and TIA
  2. Tier 1
    ESO 2021 TIA Management Guideline (for acute evaluation + prevention concepts)